Attached files

file filename
S-1 - S-1 - MARINUS PHARMACEUTICALS INCa2220119zs-1.htm
EX-4.3 - EX-4.3 - MARINUS PHARMACEUTICALS INCa2220119zex-4_3.htm
EX-3.3 - EX-3.3 - MARINUS PHARMACEUTICALS INCa2220119zex-3_3.htm
EX-3.1 - EX-3.1 - MARINUS PHARMACEUTICALS INCa2220119zex-3_1.htm
EX-10.1 - EX-10.1 - MARINUS PHARMACEUTICALS INCa2220119zex-10_1.htm
EX-10.4 - EX-10.4 - MARINUS PHARMACEUTICALS INCa2220119zex-10_4.htm
EX-10.7 - EX-10.7 - MARINUS PHARMACEUTICALS INCa2220119zex-10_7.htm
EX-10.8 - EX-10.8 - MARINUS PHARMACEUTICALS INCa2220119zex-10_8.htm
EX-10.3 - EX-10.3 - MARINUS PHARMACEUTICALS INCa2220119zex-10_3.htm
EX-10.5 - EX-10.5 - MARINUS PHARMACEUTICALS INCa2220119zex-10_5.htm
EX-10.2 - EX-10.2 - MARINUS PHARMACEUTICALS INCa2220119zex-10_2.htm
EX-10.9 - EX-10.9 - MARINUS PHARMACEUTICALS INCa2220119zex-10_9.htm
EX-10.6 - EX-10.6 - MARINUS PHARMACEUTICALS INCa2220119zex-10_6.htm
EX-10.10 - EX-10.10 - MARINUS PHARMACEUTICALS INCa2220119zex-10_10.htm
EX-10.11 - EX-10.11 - MARINUS PHARMACEUTICALS INCa2220119zex-10_11.htm
EX-10.12 - EX-10.12 - MARINUS PHARMACEUTICALS INCa2220119zex-10_12.htm

Exhibit 23.2

 

Consent of Independent Registered Public Accounting Firm

 

The Board of Directors

Marinus Pharmaceuticals, Inc.:

 

We consent to the use of our report included herein and to the reference to our firm under the heading “Experts” in the prospectus.

 

/s/ KPMG LLP

 

Philadelphia, Pennsylvania

May 12, 2014